Mutz Christopher

HEAD OF RARE DISEASEANI PHARMACEUTICALS INC (ANIP) · full profile →Form 4 · filed Feb 23, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$415K
Net Open-Market Flow
-$415K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 20, 2026Sell(S)5K$78.02$415K85K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001846487-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly: